Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.59) by 13.56 percent. This is a 69.68 percent increase over losses of $(2.21) per share from the same period last year. The company reported quarterly sales of $28.638 million which beat the analyst consensus estimate of $26.479 million by 8.15 percent. This is a 66.18 percent increase over sales of $17.233 million the same period last year.